1. Gabapentin for Neuropathic Pain.;Kamerman,2016
2. FDA: Approved Labeling: Gabapentin.
2011. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020235s036,020882s022,021129s022lbl.pdf. Accessed June 14, 2020.
3. FDA: Full prescribing information: Pregabalin.
2012. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021446s028lbl.pdf. Accessed June 14, 2020.
4. EMA: Summary of Product Characteristics: Lyrica
2009. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000546/WC500046602.pdf. Accessed June 14, 2020.
5. EMA: List of the Names, Pharmaceutical Forms, Strengths of the Medicinal Products, Route of Administration, Marketing Authorisation Holders in the Member States
2006. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Neurontin_30/WC500009308.pdf. Accessed June 14, 2020.